Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
17
TGA:17
Drug Approvals
ISTURISA osilodrostat (as phosphate) 5 mg film-coated tablet blister pack (369218)
- Product Name
- ISTURISA osilodrostat (as phosphate) 5 mg film-coated tablet blister pack
- Approval Date
- May 12, 2022
TGA
ISTURISA osilodrostat (as phosphate) 10 mg film-coated tablet blister pack (369219)
- Product Name
- ISTURISA osilodrostat (as phosphate) 10 mg film-coated tablet blister pack
- Approval Date
- May 12, 2022
TGA
ISTURISA osilodrostat (as phosphate) 1 mg film-coated tablet blister pack (369220)
- Product Name
- ISTURISA osilodrostat (as phosphate) 1 mg film-coated tablet blister pack
- Approval Date
- May 12, 2022
TGA
CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial (351010)
- Product Name
- CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial
- Approval Date
- Jan 28, 2022
TGA
QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial (321016)
- Product Name
- QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial
- Approval Date
- Apr 2, 2020
TGA
PEDEA ibuprofen 10 mg/2 mL solution for intravenous infusion 2 mL glass ampoule (273093)
- Product Name
- PEDEA ibuprofen 10 mg/2 mL solution for intravenous infusion 2 mL glass ampoule
- Approval Date
- Mar 14, 2017
TGA
SYLVANT siltuximab (rmc) 100mg powder for injection vial (229996)
- Product Name
- SYLVANT siltuximab (rmc) 100mg powder for injection vial
- Approval Date
- Aug 31, 2015
TGA
SYLVANT siltuximab (rmc) 400mg powder for injection vial (229997)
- Product Name
- SYLVANT siltuximab (rmc) 400mg powder for injection vial
- Approval Date
- Aug 31, 2015
TGA
SIGNIFOR LAR pasireotide 20 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack (225272)
- Product Name
- SIGNIFOR LAR pasireotide 20 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack
- Approval Date
- May 4, 2015
TGA
SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack (225273)
- Product Name
- SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack
- Approval Date
- May 4, 2015
TGA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found